Y-Biologics, Inc. (KOSDAQ:338840)

Y-Biologics Statistics

Total Valuation

Y-Biologics has a market cap or net worth of KRW 184.17 billion. The enterprise value is 175.49 billion.

Market Cap	184.17B
Enterprise Value	175.49B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Y-Biologics has 14.95 million shares outstanding. The number of shares has increased by 12.40% in one year.

Current Share Class	14.95M
Shares Outstanding	14.95M
Shares Change (YoY)	+12.40%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	29.34%
Owned by Institutions (%)	3.57%
Float	10.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.63
PB Ratio	10.44
P/TBV Ratio	11.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.20
EV / Sales	34.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.33

Financial Position

The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.04.

Current Ratio	8.28
Quick Ratio	8.07
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-265.88

Financial Efficiency

Return on equity (ROE) is -31.88% and return on invested capital (ROIC) is -23.69%.

Return on Equity (ROE)	-31.88%
Return on Assets (ROA)	-22.15%
Return on Invested Capital (ROIC)	-23.69%
Return on Capital Employed (ROCE)	-44.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+22.59%
50-Day Moving Average	10,024.00
200-Day Moving Average	8,767.75
Relative Strength Index (RSI)	66.97
Average Volume (20 Days)	208,945

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Y-Biologics had revenue of KRW 5.03 billion and -6.70 billion in losses. Loss per share was -634.34.

Revenue	5.03B
Gross Profit	3.75B
Operating Income	-8.27B
Pretax Income	-6.70B
Net Income	-6.70B
EBITDA	-6.29B
EBIT	-8.27B
Loss Per Share	-634.34

Balance Sheet

The company has 10.38 billion in cash and 739.55 million in debt, giving a net cash position of 9.64 billion or 645.16 per share.

Cash & Cash Equivalents	10.38B
Total Debt	739.55M
Net Cash	9.64B
Net Cash Per Share	645.16
Equity (Book Value)	17.64B
Book Value Per Share	1,128.58
Working Capital	9.50B

Cash Flow

In the last 12 months, operating cash flow was -4.75 billion and capital expenditures -2.47 billion, giving a free cash flow of -7.21 billion.

Operating Cash Flow	-4.75B
Capital Expenditures	-2.47B
Free Cash Flow	-7.21B
FCF Per Share	-482.54

Margins

Gross margin is 74.67%, with operating and profit margins of -164.54% and -133.25%.

Gross Margin	74.67%
Operating Margin	-164.54%
Pretax Margin	-133.25%
Profit Margin	-133.25%
EBITDA Margin	-125.02%
EBIT Margin	-164.54%
FCF Margin	n/a

Dividends & Yields

Y-Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.40%
Shareholder Yield	n/a
Earnings Yield	-3.64%
FCF Yield	-3.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Y-Biologics has an Altman Z-Score of 27.48 and a Piotroski F-Score of 2.

Altman Z-Score	27.48
Piotroski F-Score	2